Evolent Health, Inc. 8-K

What Happened

• Evolent Health, Inc. announced its financial results for the quarter ended December 31, 2025 via a press release dated February 24, 2026. The company furnished that press release as Exhibit 99.1 to a Form 8-K (Item 2.02: Results of Operations and Financial Condition).

Key Details

• Item reported: 2.02 (Results of Operations and Financial Condition); exhibit disclosure: 9.01(d).
• Press release furnished as Exhibit 99.1 to the Form 8-K, dated February 24, 2026.
• Quarter covered: period ended December 31, 2025.
• Form 8-K was signed by Jonathan D. Weinberg, General Counsel and Secretary, on February 24, 2026.

Why It Matters

• The press release contains the company’s latest quarterly financial results (revenue, profit/loss, and any commentary or guidance) that investors use to assess recent performance. Because the release is furnished with the Form 8-K, investors should review Exhibit 99.1 for the specific metrics and management commentary.
• After reviewing the press release, investors may want to watch for related filings (e.g., the quarterly report on Form 10-Q) or an earnings call for additional detail and context.